查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944416

全球計算病理學市場：按技術、產品類型、工作流程階段、部署方式、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）

Computational Pathology Market, By Technology, By Product Type, By Workflow Stage, By Deployment Mode, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 365 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年計算病理學市場規模價值為6.5098億美元，從2025年到2032年以9.30%的複合年成長率成長。

計算病理學是指旨在為醫療機構和病理學家提供支援的先進數位系統。這些系統利用人工智慧 (AI)、機器學習 (ML) 和影像識別等技術，為診斷、分析和操作活動提供自動化支持，以分析數位病理切片、檢測模式、量化生物標記並產生可操作的見解。這些系統有助於提高診斷準確性、減少人為錯誤並簡化病理工作流程，從而加快檢測結果的交付速度。透過自動化影像分割和資料標註等常規任務，計算病理學減少了人工操作，提高了檢查室效率。它還為病理學家和臨床醫生提供精準的、數據驅動的見解，以支持臨床決策。此外，計算病理學解決方案有助於擴展可近性的數位化診斷服務，改善患者預後，並支持醫療保健領域的大規模研究舉措。

計算病理學市場動態

數位病理平台的廣泛應用

數位病理平台的日益普及是指先進數位系統的廣泛應用，這些系統使病理學家和醫療機構能夠更有效率地管理、分析和共用病理數據。這使得高解析度病理影像、人工智慧演算法和分析應用程式能夠整合到檢查室和臨床環境中，從而提高診斷準確性和工作流程效率。在計算病理學中，這些平台有助於實現影像分析、即時數據解讀和組織樣本定量評估的自動化。因此，病理學家可以更快地獲得洞見，減少人工工作量，並提高整體診斷效能。此外，將數位病理平台與實驗室資訊系統 (LIS) 和電子健康記錄 (EHR) 整合，可確保無縫的資料流和互通性。這些平台也透過數據驅動的回饋，促進人工智慧模型的持續學習和改進。總而言之，數位病理平台的日益普及增強了現代醫療保健系統中計算病理解決方案的擴充性、可靠性和有效性。例如，2025年9月發表於《數位健康前沿》（Frontiers in Digital Health）的一項關於約旦數位病理學應用情況的研究發現，69.2%的受訪病理學家對數位病理學的了解程度高於平均水平，85%的受訪病理學家表示，如果條件允許，他們有興趣使用數位病理學工具進行診斷。這反映出專業人士對在新興醫療環境中推廣數位病理學有著強烈的意願和準備。這些數據表明，將數位病理學技術融入臨床實踐，以改善診斷流程、教育、遠端存取和研究能力，已成為持續的趨勢。

計算病理學市場：細分分析

全球計算病理學市場按技術、產品類型、工作流程階段、部署方法、最終用戶和地區進行細分。

計算病理市場通常分為三個工作流程階段：分析前、分析中、分析後。分析階段佔據了計算病理市場的大部分佔有率，因為它在實現精準的AI驅動影像分析、高效的病理解和及時的診斷報告方面發揮著重要作用。診斷報告是指以清晰有序的方式記錄和傳達醫學檢測和分析結果（例如病理學觀察）的過程，指南臨床決策和患者照護。這包括最佳化影像分析、簡化病理工作流程以及加快診斷過程，以確保及時、準確地獲得結果。分析效率的提升可以提升診斷準確性，減輕病理學家的工作量，並使檢查室能夠更有效率地處理更多檢體。在計算病理學中，分析階段的效率提升是透過基於AI的圖像解讀、組織特徵的自動量化以及快速報告生成來實現的。這些系統幫助病理學家快速分析、檢驗和確認診斷觀察，最大限度地減少人為錯誤，並確保更快、更可靠地獲得關鍵的病理結果。例如，2025 年發表在 PNAS Nexus Organization 上的一項研究報告稱，緊湊型卷積類神經網路在使用標準組織學影像區分正常淋巴結和各種淋巴瘤亞型時，診斷分類準確率 (AUC) 約為 0.87，這表明高效的 AI 驅動的計算病理學工具在臨床應用中具有很高的潛力。

根據技術的不同，計算病理學市場可分為兩大類：人工智慧技術和影像分析與視覺化技術。人工智慧技術因其能夠提高診斷準確性、擴充性和分析效率，在計算病理學市場中佔據了相當大的佔有率。這一成長部分得益於醫療保健投資的增加以及病理工作流程中先進數位技術的日益普及。人工智慧技術的可擴充性性和分析能力指的是演算法能夠高效處理大量病理影像，同時在不斷成長的資料集上保持穩定的效能。這使得檢查室能夠在不增加相應人工投入或基礎設施複雜性的情況下擴展其診斷能力。在計算病理學領域，人工智慧技術能夠實現大規模的組織樣本自動影像分析、模式識別和定量評估。這些解決方案有助於加快診斷速度、減輕病理學家的工作量，並透過從不斷成長的數據中學習來持續改進性能，從而在臨床和研究環境中提供可靠和高效的病理服務。例如，根據英國政府發布的《2024年人工智慧產業調查報告》，英國的人工智慧生態系統將在2023年至2024年間顯著擴展，人工智慧產業總收入將年增約68%，人工智慧相關就業機會將增至86,139個。這凸顯了人工智慧技術在各跨產業的快速經濟成長和廣泛應用。這種廣泛的應用顯示數位病理基礎設施日益成熟，並反映了智慧運算病理解決方案應用日益普及的趨勢。在這些解決方案中，基於人工智慧的技術能夠實現病理數據的可擴展分析，提高診斷系統之間的互通性，並支援準確、高效且數據驅動的臨床決策。

計算病理學市場—區域分析

計算病理學市場呈現出顯著的區域差異，這主要是由於醫療基礎設施、數位病理學應用以及法規環境的不同。北美地區憑藉著先進的診斷設施、早期整合的基於人工智慧的病理學解決方案、強大的研究生態系統以及美國和加拿大的高應用率，繼續佔據市場主導地位。歐洲市場正穩步成長，這得益於對精準診斷投資的增加、對數位病理學的有利監管支持以及人工智慧在病理學工作流程中的日益普及。亞太地區市場正快速擴張，這主要得益於醫療數位化的加速、癌症負擔的加重、人工智慧投資的成長以及中國、印度、日本和韓國政府的支持性政策。同時，拉丁美洲和中東及非洲市場也在逐步發展，這主要得益於檢測能力的提升、對計算病理學工具認知度的提高以及為提高診斷效率和可及性所做的努力。

美國計算病理學市場—國家分析

受先進醫療基礎設施和人工智慧診斷技術日益融合的推動，美國運算病理學市場正經歷穩定成長。醫療機構和病理檢查室正擴大採用計算病理學解決方案，以提高診斷準確性、最佳化檢查室工作流程並促進精準醫療。主要科技公司、研究機構和數位病理學解決方案提供商的積極參與，以及監管機構對人工智慧診斷技術的支持，進一步推動了市場成長。此外，對營運效率、診斷結果標準化和增強臨床決策的日益重視，也加速了醫院、診斷檢查室和研究機構對計算病理學的應用。

例如，根據IntuitionLabs發布的《醫院人工智慧：2025年應用趨勢與統計資料》報告，到2024年，約71%的美國非聯邦急診醫院將在其電子健康記錄（EHR）系統中整合預測性人工智慧解決方案，高於2023年的66%，凸顯了人工智慧在醫院環境中的加速人工智慧應用。同期，66%的美國醫生表示，到2024年，他們將在臨床實踐中使用基於人工智慧的工具，比2023年增加78%。這種廣泛的應用表明，人工智慧在美國醫療機構中，在支持臨床決策、診斷和提升營運效率方面發揮越來越重要的作用。

目錄

第1章 計算病理學市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 計算病理學的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 計算病理學市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 計算病理學市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 計算病理學市場現狀

  • 2024年計算病理學市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 計算病理學市場：依技術分類

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 深度學習/神經網路
    • 機器學習（非深度學習）
    • 電腦視覺和影像處理
    • 雲端運算和邊緣運算
    • 預測分析與指示性分析
    • 巨量資料、高效能運算 (HPC)

第8章 計算病理學市場：依產品類型分類

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 軟體
    • 服務
    • 硬體

9. 依工作流程階段分類的計算病理學市場

  • 概述
    • 細分市場佔有率分析：依工作流程階段分類
    • 預分析階段
    • 分析階段
    • 分析後階段

第10章 計算病理學市場：依部署方式分類

  • 概述
    • 細分市場佔有率分析：依部署方式
    • 本地部署
    • 基於雲端的

第11章 以最終用戶分類的計算病理學市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院和診斷檢查室
    • 生物技術和製藥公司
    • 研究機構和學術中心

第12章 計算病理學市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第13章 主要供應商分析：計算病理學產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Leica Biosystems Nussloch GmbH
    • Hamamatsu Photonics KK
    • Koninklijke Philips NV
    • F. Hoffmann-La Roche Ltd.
    • Aiforia Technologies PLC
    • Epredia
    • Visiopharm A/S
    • Proscia Inc.
    • Mindpeak GmbH
    • Others

第14章：分析師視角360度分析

簡介目錄
Product Code: ANV6045

Computational Pathology Market size was valued at US$ 650.98 Million in 2024, expanding at a CAGR of 9.30% from 2025 to 2032.

Computational Pathology refers to an advanced digital system designed to assist healthcare organizations and pathologists by providing automated support for diagnostic, analytical, and operational activities. It leverages technologies such as artificial intelligence (AI), machine learning (ML), and image recognition to analyze digital pathology slides, detect patterns, quantify biomarkers, and generate actionable insights. These systems help improve diagnostic accuracy, reduce human error, and streamline pathology workflows, enabling faster turnaround times for lab results. By automating routine tasks such as image segmentation and data annotation, computational pathology reduces manual effort and enhances laboratory efficiency. It also supports clinical decision-making by providing precise, data-driven insights to pathologists and clinicians. Moreover, computational pathology solutions facilitate the expansion of accessible and digitally enabled diagnostic services, improving patient outcomes and supporting large-scale research initiatives in healthcare.

Computational Pathology Market- Market Dynamics

Increasing use of digital pathology platforms

Increasing use of digital pathology platforms refers to the growing adoption of advanced digital systems that allow pathologists and healthcare organizations to manage, analyze, and share pathology data more efficiently. It enables the integration of high-resolution pathology images, AI algorithms, and analytical applications within laboratory and clinical environments, improving diagnostic accuracy and workflow efficiency. In computational pathology, these platforms support automated image analysis, real-time data interpretation, and quantitative assessment of tissue samples. Consequently, pathologists can generate faster insights, reduce manual workloads, and enhance overall diagnostic performance. Moreover, the integration of digital pathology platforms with laboratory information systems (LIS) and electronic health records (EHRs) ensures seamless data flow and interoperability. These platforms also facilitate continuous learning and improvement of AI models through data-driven feedback. Overall, the increasing use of digital pathology platforms strengthens the scalability, reliability, and effectiveness of computational pathology solutions in modern healthcare systems. For instance, according to a September 2025 Frontiers in Digital Health study Organization's on digital pathology adoption in Jordan, 69.2 % of surveyed pathologists demonstrated average or above average knowledge of digital pathology, and 85 % expressed interest in using digital pathology tools for diagnostic purposes if available, reflecting strong professional readiness and interest in expanding digital pathology in emerging healthcare settings. These statistics reflect a sustained trend toward integrating digital pathology technologies to improve diagnostic processes, education, remote access, and research capabilities in clinical settings.

Computational Pathology Market- Segmentation Analysis:

The Global Computational Pathology Market is segmented on the basis of Technology, Product Type, Workflow Stage, Deployment Mode, End User, and Region.

The market is commonly divided into three categories based on Workflow Stage: Pre-Analytical, Analytical, and Post-Analytical. The Analytical stage accounts for a significant portion of the Computational Pathology market due to its role in enabling accurate AI-driven image analysis, efficient pathology interpretation, and timely diagnostic reporting. Diagnostic reporting refers to the process of documenting and communicating the results of medical tests or analyses, such as pathology findings, in a clear and structured format to guide clinical decision-making and patient care. This involves optimizing image analysis, streamlining pathology workflows, and accelerating diagnostic processes to ensure timely and accurate results. Enhancing analytical efficiency improves diagnostic accuracy, reduces workload for pathologists, and enables laboratories to process more samples effectively. In computational pathology, efficiency in the Analytical stage is achieved through AI-driven image interpretation, automated quantification of tissue features, and rapid report generation. These systems help pathologists analyze, validate, and finalize diagnostic findings quickly, minimize manual errors, and ensure faster, more reliable access to critical pathology results. For instance, a 2025 study published in PNAS Nexus Organization reported that a compact convolutional neural network achieved a diagnostic classification accuracy (AUC) of around 0.87 when differentiating normal lymph nodes from various lymphoma subtypes using standard histological images, highlighting the strong potential of efficient AI-driven computational pathology tools for clinical application.

The Computational Pathology market is divided into two categories based on Technology: AI-Based Technologies and Image Analysis & Visualization Technologies. The AI-Based Technologies segment accounts for a significant portion of the Computational Pathology market due to its ability to enhance diagnostic accuracy, scalability, and analytical efficiency. This growth is partly driven by rising healthcare investments and increasing adoption of advanced digital technologies in pathology workflows. Scalability and analytical capability in AI-based technologies refer to the ability of algorithms to process large volumes of pathology images efficiently while maintaining consistent performance across growing datasets. This enables laboratories to expand diagnostic capacity without proportional increases in manual effort or infrastructure complexity. In computational pathology, AI-based technologies allow automated image analysis, pattern recognition, and quantitative assessment of tissue samples at scale. These solutions support faster diagnoses, reduce pathologist workload, and enable continuous performance improvement through learning from expanding data, ensuring reliable and efficient pathology services across clinical and research settings. For instance, according to the UK government's Artificial Intelligence Sector Study 2024, the United Kingdom's AI ecosystem expanded significantly between 2023 and 2024, with total AI sector revenue rising to approximately 68 % increase from the previous year and AI-related employment growing to 86,139 jobs, underscoring rapid economic growth and adoption of AI technologies across industries. This extensive adoption underscores the growing maturity of digital pathology infrastructure and reflects broader trends in which AI-based technologies are enabling scalable analysis of pathology data, improved interoperability across diagnostic systems, and the expanded use of intelligent computational pathology solutions to support accurate, efficient, and data-driven clinical decision-making.

Computational Pathology Market- Geographical Insights

The Computational Pathology market shows notable regional differences, largely driven by variations in healthcare infrastructure, digital pathology adoption, and regulatory environments. North America continues to dominate the market, supported by advanced diagnostic facilities, early integration of AI-based pathology solutions, strong research ecosystems, and high adoption rates in the U.S. and Canada. Europe experiences consistent growth due to rising investments in precision diagnostics, favorable regulatory support for digital pathology, and increasing use of AI across pathology workflows. Asia Pacific represents a rapidly expanding market, propelled by accelerating healthcare digitalization, growing cancer burden, increasing AI investments, and supportive government initiatives in countries such as China, India, Japan, and South Korea. In comparison, Latin America, the Middle East, and Africa are witnessing gradual market development, supported by improving laboratory capabilities, growing awareness of computational pathology tools, and efforts to enhance diagnostic efficiency and accessibility.

United States Healthcare Virtual Assistant Market - Country Insights

The U.S. Computational Pathology market is experiencing consistent growth, driven by a sophisticated healthcare infrastructure and the increasing integration of AI-based diagnostic technologies. Healthcare providers and pathology laboratories are adopting computational pathology solutions to improve diagnostic precision, optimize laboratory workflows, and advance precision medicine. Active participation from major technology companies, research institutions, and digital pathology solution providers, along with supportive regulatory developments for AI-enabled diagnostics, is further strengthening market growth. In addition, the rising emphasis on operational efficiency, standardized diagnostic outcomes, and enhanced clinical decision-making is accelerating adoption across hospitals, diagnostic labs, and research organizations.

For example, according to IntuitionLabs' AI in Hospitals: 2025 Adoption Trends & Statistics report, by 2024 nearly 71 % of non-federal acute-care hospitals in the United States had implemented predictive AI solutions integrated with electronic health record (EHR) systems, an increase from 66 % in 2023, highlighting the accelerating adoption of AI across hospital environments. During the same period, 66 % of U.S. physicians reported using AI-based tools in clinical practice in 2024, reflecting a 78 % rise compared to 2023. This widespread uptake demonstrates the growing role of AI in supporting clinical decision-making, diagnostics, and operational efficiency across U.S. healthcare institutions.

Computational Pathology Market- Competitive Landscape:

The Computational Pathology Market is moderately concentrated, with several leading medical imaging, digital pathology, and AI-focused healthcare technology companies shaping the competitive landscape. Key players include Roche Diagnostics, Philips Healthcare, Siemens Healthineers, GE Healthcare, Leica Biosystems, Hamamatsu Photonics, Olympus Corporation, 3DHISTECH, Indica Labs, PathAI, Paige AI, Proscia, Visiopharm, Aiforia Technologies, and Ibex Medical Analytics. These companies compete by offering advanced AI-driven computational pathology solutions for whole slide imaging, image analysis, tumor detection, biomarker quantification, and diagnostic decision support. For example, in 2024 Proscia advanced its Concentriq AP platform by expanding cloud-enabled digital pathology workflows and supporting multi-AI model integration, allowing pathologists to access insights from multiple AI algorithms within a unified environment. These enhancements improved slide analysis speed, diagnostic consistency, and collaboration across distributed laboratory networks. Market momentum is being driven by growing demand for precise diagnostics, automated workflows, and precision medicine applications, particularly in oncology and research. In parallel, Proscia continues to strengthen its platform with advanced AI-driven image analytics, deeper integration with laboratory information systems (LIS), regulatory-compliant software updates, and scalable cloud infrastructure, addressing the evolving requirements of pathology laboratories, hospitals, and research institutions seeking efficient, reliable, and data-centric pathology solutions.

Recent Developments:

In 2025, Roche received Breakthrough Device Designation from the U.S. FDA for its VENTANA TROP2 RxDx computational pathology companion diagnostic, reinforcing its role in advancing AI-driven precision oncology diagnostics. At the same time, PathAI launched a multi-year collaboration with Northwestern Medicine to implement its AISight image management system, aimed at enhancing diagnostic accuracy, workflow efficiency, and consistency across clinical pathology operations. These developments highlight the growing impact of computational pathology in clinical decision-making and demonstrate how strategic partnerships and regulatory advancements are driving next-generation diagnostic solutions.

In 2025, PathAI expanded FDA clearance for its AISight(R) Dx digital pathology image management system to include additional whole-slide scanners through a Predetermined Change Control Plan (PCCP). This achievement made AISight(R) Dx one of the first AI/ML pathology platforms to secure this regulatory approval pathway, improving interoperability, enabling broader lab adoption, and supporting scalable implementation in diverse pathology environments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPUTATIONAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Leica Biosystems Nussloch GmbH
  • Hamamatsu Photonics K.K
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Aiforia Technologies PLC
  • Epredia
  • Visiopharm A/S
  • Proscia Inc.
  • Mindpeak GmbH
  • Others

GLOBALCOMPUTATIONAL PATHOLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Deep Learning and Neural Networks
  • Machine Learning (Non-Deep Learning)
  • Computer Vision and Image Processing
  • Cloud Computing and Edge Computing
  • Predictive and Prescriptive Analytics
  • Big Data and High-Performance Computing (HPC)

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

  • Pre-Analytical
  • Analytical
  • Post-Analytical

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY DEPLOYMENT MODE - MARKET ANALYSIS, 2019 - 2032

  • On-Premises
  • Cloud-Based

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Diagnostic Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Research Institutes and Academic Centers

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Computational Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Computational Pathology Market Snippet by Technology
    • 2.1.2. Computational Pathology Market Snippet by Product Type
    • 2.1.3. Computational Pathology Market Snippet by Workflow Stage
    • 2.1.4. Computational Pathology Market Snippet by Deployment Mode
    • 2.1.5. Computational Pathology Market Snippet by End User
    • 2.1.6. Computational Pathology Market Snippet by Country
    • 2.1.7. Computational Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. Computational Pathology Key Market Trends

  • 3.1. Computational Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Computational Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Computational Pathology Market Opportunities
  • 3.4. Computational Pathology Market Future Trends

4. Computational Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Computational Pathology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Computational Pathology Market Landscape

  • 6.1. Computational Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Computational Pathology Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 7.1.2. Deep Learning and Neural Networks
    • 7.1.3. Machine Learning (Non-Deep Learning)
    • 7.1.4. Computer Vision and Image Processing
    • 7.1.5. Cloud Computing and Edge Computing
    • 7.1.6. Predictive and Prescriptive Analytics
    • 7.1.7. Big Data and High-Performance Computing (HPC)

8. Computational Pathology Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 8.1.2. Software
    • 8.1.3. Services
    • 8.1.4. Hardware

9. Computational Pathology Market - By Workflow Stage

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Workflow Stage, 2024&2032 (%)
    • 9.1.2. Pre-Analytical
    • 9.1.3. Analytical
    • 9.1.4. Post-Analytical

10. Computational Pathology Market - By Deployment Mode

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 10.1.2. On-Premises
    • 10.1.3. Cloud-Based

11. Computational Pathology Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 11.1.2. Hospitals and Diagnostic Laboratories
    • 11.1.3. Biotechnology & Pharmaceutical Companies
    • 11.1.4. Research Institutes and Academic Centers

12. Computational Pathology Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Computational Pathology Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Computational Pathology Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Computational Pathology Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APACMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APACMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APACMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.4.7. APACMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.4.8. APACMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. PhilippinesMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. PhilippinesMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.16.6. PhilippinesMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.16.7. PhilippinesMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Computational Pathology Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Computational Pathology Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Computational Pathology Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Leica Biosystems Nussloch GmbH
    • 13.2.2. Hamamatsu Photonics K.K
    • 13.2.3. Koninklijke Philips N.V.
    • 13.2.4. F. Hoffmann-La Roche Ltd.
    • 13.2.5. Aiforia Technologies PLC
    • 13.2.6. Epredia
    • 13.2.7. Visiopharm A/S
    • 13.2.8. Proscia Inc.
    • 13.2.9. Mindpeak GmbH
    • 13.2.10. Others

14. 360 Degree AnalystView

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us